From CRDMO to BioInnovation Venture Accelerator: A Conversation with XL Lin, CEO of Esco Aster

Esco Aster has grown beyond a CRDMO, adding on a vertically integrated bioinnovation venture accelerator, offering “idea-to-exit” support that spans consultancy, CMC development, manufacturing, testing, clinical development, business development, and strategic investment. CEO XL Lin shares how this evolution came about, what sets Esco Aster’s Metamorphosis program apart, and what advice he has for Singapore’s next generation of bioentrepreneurs.

Environmental Biotech: Southeast Asia’s Underdeveloped Potential

Southeast Asia’s cities are booming but so are its environmental challenges.

From gene-edited rice to oil-eating microbes, biotechnology is emerging as a quiet but powerful ally in tackling waste, pollution, and food security.

Our latest article explores how environmental biotech can turn these challenges into engines of resilience and growth for the region.

Singapore’s Bet on Conservation Biotechnology Aims to Preserve the Living

Can cutting-edge biotechnology help protect Southeast Asia’s endangered wildlife? At Mandai Nature, scientists are banking on it—literally. By collecting and cryopreserving live cells from threatened species like the Sunda pangolin and Celebes crested macaque, Singapore’s first conservation biobank is working to preserve genetic diversity before it’s lost forever. This pioneering effort highlights how tools once used in medicine are now being reimagined to safeguard the future of biodiversity.